GLP-1RAs are a novel class of glucose-lowering agents that mimic the physiological actions of endogenous GLP-1 by enhancing insulin secretion, reducing glucagon release, and acting on the brain to inhibit gastrointestinal motility, thereby slowing nutrient absorption
The GIP Benefit: Interestingly, the GIP (Glucose-dependent Insulinotropic Polypeptide) component of Retatrutide has shown potential in preliminary studies to support bone mineral density and potentially mitigate some muscle wasting compared to pure GLP-1 agonists
The WHO guideline also emphasized that obesity is a chronic, relapsing disease requiring long-term treatment, not a short-term intervention
Compelling evidence from landmark clinical trials, particularly STEP-HFpEF, STEP-HFpEF DM and SUMMIT, has established the efficacy of GLP-1RAs in improving HF-related symptoms and quality of life, as well as reducing worsening HF events, in the prevalent phenotype of HFpEF in the setting of obesity and T2D
Your doctor may adjust your dosage as your weight, appetite, and goals shift
Hydrates and moisturizes Dexpanthenol is a powerful humectant that attracts and retains moisture, deeply hydrating the scalp and hair